PRENATRIX- ferrous fumarate, folic acid tablet United States - English - NLM (National Library of Medicine)

prenatrix- ferrous fumarate, folic acid tablet

puretek corporation - magnesium oxide (unii: 3a3u0gi71g) (magnesium cation - unii:t6v3lhy838), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), vitamin a acetate (unii: 3le3d9d6oy) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamin - prenatrix is indicated to provide vitamins and minerals to women throughout pregnancy and during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. prenatrix may be beneficial in improving the nutritional status of women prior to conception. this product is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

NATRIXAM 1.5/5 Milligram Modified-release Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

natrixam 1.5/5 milligram modified-release tablets

les laboratoires servier - indapamide amlodipine as amlodipine besilate - modified-release tablets - 1.5/5 milligram

NATRIXAM 1.5/10 mg/mg Modified-release Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

natrixam 1.5/10 mg/mg modified-release tablets

les laboratoires servier - indapamide amlodipine as amlodipine besilate - modified-release tablets - 1.5/10 mg/mg

Natrixam 1.5mg/5mg modified-release Tablets Malta - English - Medicines Authority

natrixam 1.5mg/5mg modified-release tablets

les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - amlodipine, indapamide - modified-release tablet - indapamide 1.5 mg amlodipine 5 mg - calcium channel blockers

Natrixam 1.5mg/10mg modified-release Tablets Malta - English - Medicines Authority

natrixam 1.5mg/10mg modified-release tablets

les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - amlodipine, indapamide - modified-release tablet - indapamide 1.5 mg amlodipine 10 mg - calcium channel blockers

NATRIXAM MODIFIED RELEASE TABLET 1.5 mg10 mg Singapore - English - HSA (Health Sciences Authority)

natrixam modified release tablet 1.5 mg10 mg

servier (s) pte ltd - amlodipine besilate 13.87 mg eqv amlodipine; indapamide - tablet, multilayer, extended release - amlodipine besilate 13.87 mg eqv amlodipine 10 mg; indapamide 1.5 mg

NATRIXAM MODIFIED RELEASE TABLET 1.5 mg5 mg Singapore - English - HSA (Health Sciences Authority)

natrixam modified release tablet 1.5 mg5 mg

servier (s) pte ltd - amlodipine besilate 6.935 mg eqv amlodipine; indapamide - tablet, multilayer, extended release - amlodipine besilate 6.935 mg eqv amlodipine 5 mg; indapamide 1.5 mg